AAAAAA
Results:
1-8
|
Results: 8
Authors:
SWAIN SM
WHALEY FS
GERBER MC
WEISBERG S
YORK M
SPICER D
JONES SE
WADLER S
DESAI A
VOGEL C
SPEYER J
MITTELMAN A
REDDY S
PENDERGRASS K
VELEZGARCIA E
EWER MS
BIANCHINE JR
GAMS RA
Citation: Sm. Swain et al., CARDIOPROTECTION WITH DEXRAZOXANE FOR DOXORUBICIN-CONTAINING THERAPY IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1318-1332
Authors:
SWAIN SM
WHALEY FS
GERBER MC
EWER MS
BIANCHINE JR
GAMS RA
Citation: Sm. Swain et al., DELAYED ADMINISTRATION OF DEXRAZOXANE PROVIDES CARDIOPROTECTION FOR PATIENTS WITH ADVANCED BREAST-CANCER TREATED WITH DOXORUBICIN-CONTAINING THERAPY, Journal of clinical oncology, 15(4), 1997, pp. 1333-1340
Authors:
SWAIN SM
WHALEY FS
GAMS RA
Citation: Sm. Swain et al., DELAYED ADMINISTRATION OF DEXRAZOXANE PROVIDES CARDIOPROTECTION AGAINST ANTHRACYCLINES IN BREAST-CANCER OR ACUTE MYELOID-LEUKEMIA - REPLY, Journal of clinical oncology, 15(10), 1997, pp. 3294-3295
Authors:
WOOLLEY PV
SCHULTZ CJ
RODRIGUEZ GI
GAMS RA
ROWE KW
DADEY ML
VONHOFF DD
MCPHILLIPS JJ
Citation: Pv. Woolley et al., A PHASE-II TRIAL OF ILMOFOSINE IN NONSMALL CELL BRONCHOGENIC-CARCINOMA, Investigational new drugs, 14(2), 1996, pp. 219-222
WORSENING BONE-SCAN IN THE EVALUATION OF ANTITUMOR RESPONSE DURING HORMONAL-THERAPY OF BREAST-CANCER
Authors:
VOGEL CL
SCHOENFELDER J
SHEMANO I
HAYES DF
GAMS RA
Citation: Cl. Vogel et al., WORSENING BONE-SCAN IN THE EVALUATION OF ANTITUMOR RESPONSE DURING HORMONAL-THERAPY OF BREAST-CANCER, Journal of clinical oncology, 13(5), 1995, pp. 1123-1128
Authors:
SPENCER DM
BIGLER LR
WILKIN JK
GAMS RA
Citation: Dm. Spencer et al., UTERINE ADENOCARCINOMA METASTATIC TO THE SKIN RESPONSIVE TO MEGESTROL-ACETATE, The Journal of dermatologic surgery and oncology, 20(8), 1994, pp. 544-547
Authors:
ZUCKERMAN KS
CASE DC
GAMS RA
PRASTHOFER EF
Citation: Ks. Zuckerman et al., CHEMOTHERAPY OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH AN INTENSIVE EPIRUBICIN-CONTAINING REGIMEN, Blood, 82(12), 1993, pp. 3564-3573
Authors:
ZUCKERMAN KS
CASE DC
GAMS RA
PRASTHOFER EF
Citation: Ks. Zuckerman et al., A HIGH-DOSE EPIRUBICIN-BASED REGIMEN (EVDAC) IS HIGHLY EFFECTIVE 1ST-LINE CHEMOTHERAPY FOR INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMAS, Blood, 82(10), 1993, pp. 10000136-10000136
Risultati:
1-8
|